EGF Topical Solution 0.005% (Recombinant Human Epidermal Growth Factor)
Recombinant Human Epidermal Growth Factor (Host: Escherichia Coli JM101, Vector: pTE105) 0.5mg
Solution · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
MFDS item code 199700704 · Approved 1997.03.04 · Insurance code 641602122
Blood sugar control and treatment of diabetic foot ulcers
This medication is used for the treatment of foot ulcers, namely diabetic foot ulcers, occurring in diabetic patients with poor blood sugar control. It is mainly applicable to patients whose fasting blood sugar is 140 mg/dl or higher or whose HbA1c exceeds 8%, and helps promote wound healing to prevent infections and complications. This treatment is important in improving the quality of life of patients and reducing the occurrence of serious complications. Therefore, it is actively used for the treatment of diabetic foot ulcers.
After mixing this drug with the accompanying solvent thoroughly, apply an appropriate amount to the affected area twice a day.
This drug should not be used in patients with hypersensitivity to the active ingredient. It is also advisable not to use this drug in patients with malignant tumors at the application site or a history of malignant tumors. Patients with systemic or localized infections should only use this drug after the infection has been adequately treated and improved. Patients with a history of malignant tumors should use this drug cautiously. The use of this drug may result in pain, redness, hyperplasia at the application site, elevated liver enzymes, as well as pain in the back or muscles, and neck area. In clinical trials, ulcers, pain and infection at the ulcer site, and elevated liver enzymes were reported as side effects in patients using this drug. After use, redness of the skin or excessive tissue growth may occur, requiring caution. Patients with diabetic foot ulcers and conditions such as sepsis, osteomyelitis, abscess, connective tissue diseases, a history of malignant tumors, or poor nutritional status have not had the safety and efficacy of this drug established, so caution is advised in these cases. It is important to confirm the presence of malignant tumors before using this drug. The safety of this drug has not been established in pregnant or breastfeeding women, so it is best to avoid use. This drug has not been studied for safety and efficacy in children, so its use is not recommended. This drug should be used on areas of the wound that have good blood circulation and are free of infection. The wound area should be cleaned with sterile saline before use. This drug has no antibacterial action, so infection treatment is necessary for infected wounds before its use. When used, it is important to mix the active ingredient with the accompanying solvent. Please verify that spraying works well when using for the first time. When spraying on the wound area, maintain a distance of about 5-10cm, and spray sufficiently to cover the entire wound. After application, dressing should be done only after waiting for it to completely dry. The mixed solution should be used within 6 months and must be stored refrigerated (2-8°C). It is safe to store it out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent exposure to air or moisture. Also, it is important to store it in the refrigerator at a temperature between 2 to 8 degrees Celsius to maintain freshness and effectiveness.
A colorless, transparent liquid in a pump spray bottle divided into two compartments, which forms a colorless, transparent topical solution when mixed with the accompanying solvent.
1 unit/box [10ml (spray bottle)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Recombinant Human Epidermal Growth Factor (Host: Escherichia Coli JM101, Vector: pTE105) 0.5mg
Solution · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Recombinant Human Epidermal Growth Factor (Host: Escherichia Coli JM101, Vector: pTE105) 1μg
Ointment · OTC medication
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.